Bioactive natural products are a potential source of new pharmaceuticals since they offer new modes of action and more specific activities. The use of derivatization also enables the optimal structure for their biological activity to be determined. In this study several epoxycurcuphenol derivatives were synthesized. The substitution pattern on the aromatic and oxirane rings was varied along with that at the benzylic position and the length of the side chain was altered. These changes were made in order to gain a deeper understanding of the structural requirements for activity. The biological activities of these compounds were evaluated on the human leukemia cell line Jurkat using an antiproliferative assay. The activity results and structural requirements are discussed.
Introduction
Bioactive natural products are a potential source of new pharmaceuticals 1,2 since they offer new modes of action and more specific interactions. Among the plants and microorganisms from which allelopathic agents have been isolated, Helianthus annuus L. (sunflower) is very interesting because of its high production of secondary metabolites 3 especially in sesquiterpene lactones, 4, 5 heliespirones, 6, 7 annuionones, 8 helibisabonols, 9 heliannuols 10, 11 and phenolic compounds. 12 Heliannuols, a new class of compounds isolated from Helianthus annuus, constitute a family of new compounds with a novel heterocyclic sesquiterpene structural backbone named heliannane. 13 This skeleton is characterized by a benzenoid moiety fused to a five-to eight-membered heterocyclic ring. Among these compounds, heliannuol D (1) (Fig. 1 ) has special relevance due to the high phytotoxic activity it has shown. 14 The fact that these allelochemicals may be useful for developing new active compounds makes their synthesis at large scale an attractive goal. 15 Besides the synthetic analogous and intermediates obtained during their synthesis are also of interest, since their bioactivity offers hints about the structural requirements needed.
In the course of our research toward the synthesis of heliannuol D (1) 16 we obtained two aromatic diasteroisomers that present an oxirane group (2a, 2b) ( Fig. 1 ). They showed interesting biological activities when evaluated in animal cells. Compounds 2a and 2b were evaluated for their effects on cytokine production by human primary CD4+ T cells and on cell division on the human tumoral cell line Jurkat, murine antigen specific CD4+ T cell line D5, murine Primary CD4 T Cells from TcR (T cell receptor) Transgenic DO11.10 mice, human primary naïve PBMC and human primary CD4+ T cells. In the case of the lymphoid human cell line Jurkat, addition of sesquiterpenes at a final concentration of 1 lM impaired cell division in almost 100% of cells. 17 In order to gain a deeper understanding of the structural requirements for bioactivity in this family of compounds we carried out a Structure-Activity Relationship (SAR) study and ⇑ Corresponding author.
E-mail address: famacias@uca.es (F.A. Macías). (Fig. 2) . We changed the number and position of hydroxyl groups, the presence of additional methyl or ethyl groups in the aromatic ring and/ or in the side chain and the pattern of substitution in the aromatic ring. The compounds were classified into three families depending on the length of the side chain and the substitution pattern at the oxirane ring: C6 (oxirane ring with two methyl groups in the last carbon, and a side chain that is six carbons in length; compounds 2-7), C5 (with a side chain five carbons long and the oxirane ring without any terminal methyl groups; compounds 8-13) and C4 (with a four-carbon side chain and an oxirane ring without any methyl group; compound 14) (Fig. 2) . All compounds were obtained as a pair of diastereoisomeric products apart from compounds 4 and 10.
Chemistry
A total of 24 compounds were synthesized (Fig. 2) ; 18 of them were tested for antiproliferative potential (Jurkart cell line from leukemia CT-CD4) to evaluate different modifications on the basic skeleton of 2a and 2b. The synthesis is based on that of heliannuol D and resembles the biogenetic route proposed for heliannuols and helibisabonols, where compounds 2a and 2b are intermediates proposed in this biogenetic route. 10, 11, 18 Thus, the synthetic procedure used herein has two main stages. The first stage involves the preparation of the appropriate aromatic bisabolene skeleton 19 from a benzenoid precursor (2-methylhydroquinone 15 as starting material) with the desired substitution pattern in the aromatic ring and the correct side chain obtained according the procedures reported by our group (Scheme 1). 16 The second stage of the synthesis (Scheme 2) hasthree steps and these are slightly different to those reported previously. The first step was the reduction of the hydroxyl group at C-7 (20) and this was achieved using triethylsilane in dichloromethane and BF 3 OEt 2 as catalyst to give the desired product in 70% yield. Subsequent epoxidation of 20 gave compound 21 in 84% yield. Finally, palladium-catalyzed (Pd/C) hydrogenation of 21 led to selective cleavage of the benzylic ethers to yield the pair of diastereoisomers 2a and 2b in 45% yield each. These compounds could be separated by HPLC. Depending on the nature of the starting material, this synthetic methodology led to the corresponding pairs of diastereoisomers shown in Figure 2 . The intermediates are shown in the Supplementary data, although some reactions needed to be slightly modified depending on the specific reactivity requirements of the intermediates. For example, the dehydroxylation reaction to give the precursors of 4 and 10 required the use a large excess (10 equiv) of triethylsilane and the reaction was carried out at 0°C. The epoxidation in the C5 series was performed with an increased amount of m-CPBA and a longer reaction time. All pairs of diastereoisomers were separated and purified by HPLC techniques, with the exception of 14a and 14b, which could not be isolated. In the hydrogenation reactionto obtain 13a and 13b it was impossible to remove the aromatic hydroxyl group without affecting the oxirane ring. In this case, the final compounds were those resulting from reductive cleavage of the oxirane ring. The absence of terminal methyl groups in the oxirane ring of compounds in C5 markedly changed the reactivity of the system and this is the probable cause of this behaviour.
Results and discussion

Synthesis
The synthetic procedure used for the pair of diastereoisomers 2a and 2b has been used and optimized to obtain the complete family of compounds presented. Only slight modifications were necessary in the synthesis of some compounds, with changes to the amount of reagent or the reaction temperature, as described in the Experimental section, to improve yields. All reactions proceeded with good yields (between 40 and 95%) (Supplementary data page S6). 
Relative stereochemistry
The final compounds 2a/2b to 14a/14b have two chiral centres at C-7 and C-10 (in the C6 and C5 series) or C-7 and C-9 (in the C4 series) that provide two pairs of diastereoisomers each (except for 4 and 10, which have one asymmetric centre). The relative stereochemistry of each diastereoisomer was elucidated by NMR and theoretical conformational studies that will be discussed below.
The structures of all compounds were determined by spectroscopic methods ( (Fig. 3 ). These facts could suggest an intramolecular bonding in one of the isomer, which influence its polarity.
Such differences suggest the presence of a rotational barrier through the C-8/C-9 bond where the two protons are differentiated. A careful study of the structure of compounds 2a/2b shows that a hydrogen bond can be established between the aromatic hydroxyl group and the oxirane ring. Such a bond provides enough rigidity to differentiate the two H-8 signals.
A theoretical model was developed for each diastereoisomer using PCMODEL with GMMX (Global-MMX) calculations and MOPAC (Molecular Orbital PACkage) 19, 20 to obtain the minimum energy conformers that contain a hydrogen bond. In the case of the 7R*10R* diastereoisomer two minimum energy conformers bearing the hydrogen bridge were found (Table 1 ), but none of these had dihedral angles with coupling constants similar to the experimental values. Two conformers were also found for the 7S*10R* isomer. In this case the theoretical coupling constants were similar to the experimental values. Consequently, a relative stereochemistry 7S*10R* is proposed for compound 2b and a relative stereochemistry 7R*10R* for 2a. The 3D representations of the selected conformers for each compound are shown in Figure 4 , where the hydrogen bond formed between the aromatic hydroxyl group and the oxirane ring on 2b can be observed. The same theoretical study was carried out for the rest of the compounds obtained, allowing us to propose the relative stereochemistries shown in Table 2 .
Antiproliferative assay on human cells
In this bioassay, we analyse cell division as the end point of cell proliferation. Cells were exposed to test compounds at a concentration of 10 lM for 24 h, stained with CFSE (Carboxyfluorescein succinimidyl ester) [21] [22] [23] and analysed by flow cytometry 4 days later to determine size distribution and the level of cell division. The effect of the active compound can be detected from a shift in the population curve to the left when compared to the control curve. This change is due to dilution of the CFSE dye between dividing cells. The effect was quantified using a flow cytometer (Cyan ADP MLE ™, Bechman ™) to count dividing and non-dividing cells. Several parameters have been compared to show the activity of the compound in comparison with the control value, with the results expressed as the Proliferation Index (PI, a measure of the increase in cell numbers in the culture) and Nonproliferative Fraction (NpF, which represents the fraction in the original culture cells that have not proliferated during the course of the experiment). The results are shown in Table 3 and Figure 5 .
Of the compounds tested, those with two aromatic hydroxyl groups are the most active. This effect is clear on comparing compounds that differ only in the number of aromatic hydroxyl groups; for example, in the C6 series, 2a (NpF: 0.87) and 2b (NpF: 0.92) are more active than 5a (NpF: 0.41) and 5b (NpF: 0.42), and the same effect can be observed with 8a (NpF: 0.86) and 8b (NpF: 098) when compared to 11a (NpF: 0.37) and 11b (NpF: 0.30) in the C5 series (Fig. 5) .
The substituent at the benzylic position (C-7) also modifies the activity. In this case, the optimal group in this position is hydrogen, as shown by comparison of the bioactivities of compounds 3b, 4 and 6b (Table 3) . Thus, 4 does not have a substituent at C-7 and it is the most active compound (NpF: 0.94), followed by 6b (NpF: 0.62) and 3b (NpF: 0.39), which have an ethyl and a methyl substituent, respectively. Other structural factors analysed were the substitution pattern of the oxirane ring, polarity of compounds and the relation with the stereochemistry and the presence or absence of an aromatic methyl group at C-4 position.
The substitution pattern on the oxirane ring affects the activity by enhancing the effect produced by the factors discussed above. In most cases, compounds of the C5 series without methyl groups on the oxirane ring show lower activities than compounds of the C6 series that contain two methyl groups at the end of the side chain on the oxirane ring as the only difference. Comparison of the activities of 5a/5b (NpF: 0.42/0.41) with 11a/11b (NpF: 0.37/0.30) or 2a (NpF: 0.87, PI: 1.62) versus 8a (NpF: 0.86, PI: 1.85)) illustrates this behaviour (Table 3 ). This trend is particularly pronounced in the comparison of the active compounds 6a/6b (NpF: 0.59/0.62) with the inactive compounds 12a/12b (NpF: 0.40/0.42). This behaviour can be due to the +I inductive effect of methyls over oxirane ring increasing the reactivity of this moiety and then their toxicity. 24 For active compounds, the most polar one in every pair of diastereoisomers, corresponding to the relative stereochemistry 7S*,10R* (Table 2) , is also the most active. Thus, 8b (PI: 1.09; NpF: 0.98) is more active than 8a (PI: 1.85; NpF: 0.86) and 2b (PI: 1.36; NpF: 0.92) is more active than 2a (PI: 1.62; NpF: 0.87) (Fig. 5) .
The aromatic methyl group is another requirement for activity in this kind of compound. All compounds that do not bear an aromatic methyl at the C-4 position (3b, 4, 6a, 6b, 7a, 7b, 12a, 12b , 13a, 13b) are inactive with the exceptions of 4 (PI: 1.11; NpF: 0.94) and 6a/6b (PI: 2.73/3.04; NpF: 0.59/0.62). These values, which are very similar to those of the control and have a high population percentage in the 4th and 5th generation, are indicative of low activity. The activity of 4 is due to the fact that other structural requirements outlined below, for example two aromatic hydroxyl groups and/or the absence of a substituent at the benzylic position should have more relevance. Thus, the most active diastereoisomeric pairs are 2a/2b and 8a/8b, all of which have an aromatic methyl at C-4. Evermore, if we compare the activity of 2b (NpF: 0.92) and 3b (NpF: 0.399) with a methyl group on C-4 as only difference in their structure, we can determine that this substitution has an important influence on the activity of the compounds.
The most effective compound in this bioassay was 7S*,10R*-12,13-dinor-10,11-epoxy-10,11-dihydrocurcuhydro-quinone (8b), which fits the requirements described. Its effect can be shown with the shift in the population curve to the left when compared to the control curve (Fig. 6 ).
Conclusions
We have developed a facile synthetic route to epoxycurcuphenol derivatives that contain two chiral centres. These compounds Table 2 Relative stereochemistry propose for each couple of diastereoisomers Diastereoisomers Stereochemistry Diastereoisomers Stereochemistry 2a/2b 7R*10R*/7S*10R* 8a/8b 7R*10R*/7S*10R* 3a/3b 7R*10R*/7S*10R* 9a/9b 7R*10R*/7S*10R* 5a/5b 7S*10R*/7R*10R* 11a/11b 7R*10R*/7S*10R* 6a/6b 7R*10R*/7S*10R* 12a/12b 7S*10R*/7R*10R* 7a/7b 7S*10R*/7R*10R* 13a/13b 7S*10R*/7R*10R* are obtained as pairs of diastereoisomers and their relative stereochemistries were determined by NMR spectroscopy and theoretical molecular studies. We have studied the structure-activity relationship (SAR) in epoxycurcuphenols using the results from the antiproliferative potential in animal cells; it was possible to determine the structural requirements for optimal activity.
The main requirements for activity are: The compounds should have two aromatic hydroxyl groups without any substitution at the C-7 position. Moreover, the activity is improved when the relative stereochemistry is 7S*,10R*, a methyl group is present in the aromatic C-4 position and an monosubstituted oxirane ring is present. The most active compound synthesized was 8b (7S*, 10R*-12,13-dinor-10,11-epoxy-10,11-dihydro-curcuhydroquinone) and this has excellent Proliferation Index and Nonproliferative Fraction values (1.09 and 0.98, respectively).
In relation to the compounds that showed significant activity against animal cells, it would be of great interest to carry out further studies into phenomenon by making slight modifications to the structure and testing the resulting compounds in other bioassays in an effort to identify their mode of action. 13 C NMR and HRMS data are identical to those published previously.
2,5-Dibenzyloxy-4-methylacetophenone (18).
The crude product was purified by column chromatography (hexane/ EtOAc 20%) to yield 2,5-dibenzyloxy-4-methylacetophenone (18) (95%). The product has identical spectroscopic data to those reported previously (IR, 1 H and 13 C NMR, HRMS). 16 
2-O,5-O-Dibenzyl-7-hydroxy-curcuhydroquinone (19).
A catalytic amount of I2 dissolved in dry THF (1 mL) was added under a N2 atmosphere to a dry flask with calcined magnesium (2 equiv). A solution of the aromatic compound 18 and 5-bromo-2-methyl-2-pentene (3 equiv) in dry THF (0.075 M in compound 18) was added slowly with continuous stirring. The colour of the reaction change from muddy red to clear yellow and after 10 min the reaction was quenched with NH4Cl (sat) and extracted with AcOEt (Â5). The combined organic layers were dried over anhydrous Na 2 SO 4 and the solvent was evaporated under vacuum. The reaction mixture was separated by column chromatography (hexane/ethyl acetate 95:5). Compound 19 was obtained in 89% yield and the spectroscopic data are identical to those published by Macias et al. 16 
2-O,5-O-Dibenzyl-curcuhydroquinone (20).
Et 3 Si (1 equiv) and BF 3 Et 2 (0.5 equiv, dropwise) were added to 500 mg of 19 in DCM (0.02 M) under a N 2 atmosphere and the Figure 6 . Population curves for the most active compound (8b) vs control, the cell division with 8b is virtually nonexistent. mixture was stirred at -78°C. After 15 min the temperature was raised to -55°C and the reaction mixture was stirred for 12 h under these conditions. The reaction was quenched with a saturated solution of NaHCO 3 and extracted with DCM (Â3). The organic layer was dried over anhydrous Na 2 SO 4 , filtered and the solvent was evaporated. 
5.1.2.7.
7R*,10R*-10,11-Epoxy-10,11-dihydrocurcuhydro-quinone (2a) and 7S*,10R*-10,11-epoxy-10,11-dihydro-curcuhydroquinone (2b).
Pd/C (50%w) was added to a solution of 21 (50 mg) in dry N,N-dimethylformamide (DMF) and the mixture was placed under a H 2 atmosphere. The reaction mixture was stirred for 2 h and was then filtered through a silica column with EtOAc (25 mL) as the mobile phase. The crude product was washed with water (Â5) to remove DMF. The organic layer was dried over anhydrous Na 2 SO 4 , filtered and the solvent was evaporated under vacuum. The mixture was purified by column chromatography (hexane/EtOAc 40%). Compounds 2a and 2b were obtained in 51% and 45% yield, respectively. The spectroscopic data have been reported previously for these compounds, with the same values for IR and HRMS, although the 1 H NMR and 13 C NMR spectra were obtained with deuterated acetone as solvent. (C-14), 25.0 (C-12), 27.9 (C-9), 32.6 (C-7), 34.9 (C-8), 58.1 (C-11), 64.7 (C-10), 113.9 (C-3), 118.5 (C-6), 122.6 (C-4), 131.7 (C-1), 148.0 (C-5), 149.3 (C-2).
5.1.2.9.
7S*,10R*-10,11-Epoxy-10,11-dihydrocurcuhydro-quinone (2b). 
Synthesis of compounds 3a and 3b to 14a and 14b
Each pair of diastereoisomers of series' C6, C5 and C4 (Fig. 2 ) was synthesized by the same methodology used to obtain compounds 2a and 2b described in the last section, although several changes were made to the conditions in certain stages. Reductions of the hydroxyl group in C-7 to obtain 4 and 10 and epoxidation of compounds in the C5 and C4 series' (48, 51, 54, 57, 60, 63 and 66) were modified slightly. The selective cleavage of the benzyl groups was carried out under the same conditions for all compounds, but hydrogenation of 64 led to the reduced product 65 with the loss of the oxirane ring and only one hydroxyl group in C-10.
All synthetic details, including 1 H NMR (CDCl 3 or C 2 D 6 O, 400 MHz) and 13 C NMR (CDCl 3 or C 2 D 6 O, 100 MHz) data for these compounds are given in the Supplementary data.
Bioassay
General
For flow cytometry analysis, 10,000 live events were collected on a Cyan-ADP-MLE II flow cytometer (DakoCytomation™). Acquisition and analysis were performed using summit software (DakoCytomation™).
Cell culture and stimulation
The cell line Jurkat (American Type Culture Collection, Manassas, VA, USA) was maintained routinely in RPMI-1640 medium ((Roswell Park Memorial Institute medium) supplemented with 2 mM L-glutamine, 10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 10% FBS (Fetal bovine serum), 1% nonessential amino acids (NEAA), 1% sodium pyruvate, and 1% penicillin/streptomycin at 37°C).
CFSE cell division assay
For the CFSE cell division assay, cells were washed and 
